Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Schering-plough Corporation Patent Department (k-6-1, 1990) patentsThe following is a sampling of recent Schering-plough Corporation Patent Department (k-6-1, 1990) patent applications (USPTO Patent Application #, Patent Title) sorted by month.
April 2008 - Schering-plough Corporation Patent Department (k-6-1, 1990) patents
20080095740 - Piperidine derivatives useful as ccr5 antagonists
20080089858 - Azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabolism
20080089890 - Methods of polypeptide production
20080090242 - Panel of biomarkers for prediction of fti efficacy
20080090823 - Thiadiazoles as cxc- and cc- chemokine receptor ligands
20080090830 - Bicyclic and tricyclic derivatives as thrombin receptor antagonists
20080090993 - Purified mammalian cytokines; related reagents and methods
20080083416 - Footcare product dispensing kiosk
20080085262 - Purified mammalian cytokines; related reagents and methods
20080085923 - Thrombin receptor antagonists based on the modified tricyclic unit of himbacine
20080081024 - Photoprotective compositions comprising synergistic combination of sunscreen active compounds
20080081360 - Erk2 crystals
March 2008 - Schering-plough Corporation Patent Department (k-6-1, 1990) patents
20080072461 - Cushioned orthotic
20080076750 - Azetidinone derivatives and methods of use thereof
20080076751 - Azetidinone derivatives and methods of use thereof
20080066744 - Process for producing metered dose inhaler formulations
20080070888 - Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism
20080070889 - Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism
20080070890 - Spirocyclic azetidinone compounds and methods of use thereof
20080070892 - Treating pain, diabetes, and disorders of lipid metabolism
20080064674 - Pharmaceutical compositions
20080064713 - Dry syrup containing loratadine
20080057032 - Combination therapy (temozolomide and alpha-ifn) for advanced cancer
20080058306 - Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitors(s) and treatments for vascular indications
20080058343 - Heterocyclic substituted piperazine compounds with cxcr3 antagonist activity
20080058354 - Xanthine phosphodiesterase v inhibitors
20080058370 - 1-[[1-[(2-amino-6-methyl-4-pyridinyl)methyl]-4-fluoro-4-piperidinyl]carbonyl]-4-[2-(2-pyridinyl)-3h-imidazo[4,5-b]pyridin-3-yl]piperidine and methods of use thereof
20080058518 - Process and intermediates for the synthesis of (3-alkyl-5-piperidin-1-yl-3,3a-dihydro-pyrazolo[1,5-a]pyrimidin-7-yl)-amino derivatives and intermediates
February 2008 - Schering-plough Corporation Patent Department (k-6-1, 1990) patents
20080050384 - Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
20080051579 - Process for resolving chiral piperidine alcohol and process for synthesis of pyrazolo[1,5-a] pyrimidine derivatives using same
20080044432 - Mammalian receptor proteins; related reagents and methods
20080044835 - Mammalian chemokine reagents
20080045489 - 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
20080045568 - Novel high affinity quinoline-based kinase ligands
20080045698 - Mammalian receptor proteins; related reagents and methods
20080045718 - Process and intermediates for the synthesis of 2-(quinolin-5-yl)-4,5 disubstituted-azole derivatives
20080039439 - Alpha2c adrenoreceptor agonists
20080039474 - Novel heterocyclic substituted pyridine compounds with cxcr3 antagonist activity
20080031943 - Immediate-release tablet formulations of a thrombin receptor antagonist
January 2008 - Schering-plough Corporation Patent Department (k-6-1, 1990) patents
20080025974 - Human receptor proteins; related reagents and methods
20080026009 - Borrelia burgdorferi bacterin
20080026050 - Solid dose formulations of a thrombin receptor antagonist
20080027063 - Imidazopyrazines as protein kinase inhibitors
20080027100 - Functionally selective alpha2c adrenoreceptor agonists
20080027101 - Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline compound
20080019978 - Nitrogen-containing heterocyclic compounds and methods of use thereof
20080020055 - Phenylephrine pharmaceutical formulations and compositions for colonic absorption
20080021019 - Kinase inhibitors
20080021100 - Pharmaceutical formulations and compositions of a selective antagonist of either cxcr2 or both cxcr1 and cxcr2 and methods of using the same for treating inflammatory disorders
20080014197 - Neutralizing human anti-igfr antibody
20080009651 - Synthesis of 3-(5-nitrocyclohex-1-enyl) acrylic acid and esters thereof
20080004248 - 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
20080004257 - Kinase inhibitors
20080004286 - Method of using substituted piperidines that increase p53 activity
20080004287 - Substituted piperidines that increase p53 activity and the uses thereof
20080004318 - Substituted bicyclic and tricyclic thrombin receptor antagonists
20080004449 - Synthesis of diethyl{[5-(3-fluorophenyl)-pyridine-2yl]methyl}phosphonate
December 2007 - Schering-plough Corporation Patent Department (k-6-1, 1990) patents
20070289170 - Adjustable orthotic
20070286874 - Recombinant attenuated clostridium organisms and vaccine
20070287664 - Combinations of hcv protease inhibitor(s) and cyp3a4 inhibitor(s), and methods of treatment related thereto
20070287692 - Aspartyl protease inhibitors
20070281019 - Phenylephrine pulsed release formulations and pharmaceutical compositions
20070281020 - Pharmaceutical compositions for sustained release of phenylephrine
20070281951 - Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
November 2007 - Schering-plough Corporation Patent Department (k-6-1, 1990) patents
20070274951 - Combinations comprising hcv protease inhibitor(s) and hcv polymerase inhibitor(s), and methods of treatment related thereto
20070275051 - Pharmaceutical formulations: salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same
20070275963 - Pyrazolo[1,5-a]pyrimidines
20070275983 - Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
20070270439 - Thrombin receptor antagonists
20070264230 - Thiadiazoledioxides and thiadiazoleoxides as cxc- and cc-chemokine receptor ligands
20070264672 - Development of a novel assay for mgmt (methyl guanine methyl transferase)
20070265299 - Compounds for the treatment of inflammatory disorders
20070258947 - Depeptidized inhibitors of hepatitis c virus ns3 protease
20070254952 - Cannabinoid receptor modulators
20070255044 - Mammalian galanin receptors
October 2007 - Schering-plough Corporation Patent Department (k-6-1, 1990) patents
20070248594 - Cxcr1 and cxcr2 chemokine antagonists
20070249043 - Adenoviral expression vectors
20070249604 - 3-monosubstituted tropane derivatives as nociceptin receptor ligands
20070244052 - Methods for identifying agonists or antagonists of cd200r signaling molecules and methods of using the same
20070244142 - Hydrochloride salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy)-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor
20070244163 - Fused ring thrombin receptor antagonists
20070237818 - Controlled-release formulation of hcv protease inhibitor and methods using the same
20070238674 - Tra combination therapies
20070238700 - N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
20070238755 - Methods to treat and/or prevent radiation- and/or chemical-induced toxicity in non-malignant tissue
20070238874 - Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
20070231301 - Parenteral low dose type 1 interferons for bladder cancer
20070232527 - Medicaments and methods combining a hcv protease inhibitor and an akr competitor
20070232549 - Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
20070232610 - Novel compounds that are erk inhibitors
20070232635 - Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists
September 2007 - Schering-plough Corporation Patent Department (k-6-1, 1990) patents
20070225270 - Pyrazolopyrimidines as cyclin dependent kinase inhibitors
20070219154 - Methods for preventing and/or treating a cell proliferative disorder
20070219218 - Compounds for the treatment of inflammatory disorders
20070213340 - Farnesyl protein transferase inhibitors
20070207949 - Medicaments and methods combining a hcv protease inhibitor and an akr competitor
August 2007 - Schering-plough Corporation Patent Department (k-6-1, 1990) patents
20070202050 - Pharmaceutical formulations
20070202055 - Pharmaceutical formulations
20070202140 - Thrombin receptor antagonists as prophylaxis to complications from cardiopulmonary surgery
20070203104 - Pharmaceutical formulations
20070203149 - Ccr5 antagonists useful for treating hiv
20070203183 - Diaryl piperidines as cb1 modulators
20070203193 - Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
20070203339 - Process for preparation of cyclic prodrugs of pmea and pmpa
20070203340 - Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
20070197448 - Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease
20070197564 - Compounds for the treatment of inflammatory disorders
20070197581 - Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
20070197628 - Cannabinoid receptor modulators
20070189993 - Stabilized photoprotective composition
20070191332 - Compounds for the treatment of inflammatory disorders
20070191604 - Novel compounds that are erk inhibitors
20070179187 - Thrombin receptor antagonists
July 2007 - Schering-plough Corporation Patent Department (k-6-1, 1990) patents
20070173495 - Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
20070166280 - Chemokines as adjuvants of immune response
20070167426 - Compounds for the treatment of inflammatory disorders and microbial diseases
20070167435 - Phenoxypiperidines and analogs thereof useful as histamine h3 antagonists
20070160549 - Uv-radiation protectant compositions
20070161578 - Treatment of nonalcoholic fatty liver disease using cholesterol lowering agents and/or h3 receptor antagonist/inverse agonist
20070155674 - Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
20070155675 - Substituted azetidinone compunds, processes for preparing the same, formulations and uses thereof
20070155676 - Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
20070155751 - Novel imidazopyrazines as cyclin dependent kinase inhibitors
20070155756 - Treatment of chemokine mediated diseases
20070155799 - Carbonates of fenicol antibiotics
June 2007 - Schering-plough Corporation Patent Department (k-6-1, 1990) patents
20070148669 - Modified tumor necrosis factor-alpha converting enzyme and methods of use thereof
20070149459 - Oxidation process for the preparation of n-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-{n-[(tert-butylamino)carbonyl]-3-methyl-l-valyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide and related compounds
20070149518 - Oxazoloisoquinoline derivatives as thrombin receptor antagonists
20070141024 - Mammalian cytokine; reagents and methods
20070141603 - Mammalian tnf-alpha convertases
20070142300 - Novel compounds as inhibitors of hepatitis c virus ns3 serine protease
20070142301 - Novel inhibitors of hepatitis c virus ns3 protease
20070142369 - Combination of an h3 antagonist/inverse agonist and an appetite suppressant
20070142394 - Substituted aniline derivatives useful as histamine h3 antagonists
20070128159 - Chemokines as adjuvants of immune response
20070129378 - Compounds for the treatment of inflammatory disorders and microbial diseases
May 2007 - Schering-plough Corporation Patent Department (k-6-1, 1990) patents
20070122355 - Rapidly absorbing oral formulations of pde 5 inhibitors
20070122800 - Methods for quantifying polymer attachment to a particle
20070123538 - Compositions comprising a combination of ccr5 and cxcr4 antagonists
20070116703 - Isolated mammalian membrane proteins; related agents
20070116730 - Pharmaceutical compositions
20070117155 - Histamine receptor
20070117804 - Imidazopyrazines as protein kinase inhibitors
20070117828 - Pharmaceutical compositions
20070111979 - Methods of treating cell proliferative disorders using a compressed temozolomide dosing schedule
20070112053 - Pharmaceutical compositions and methods using temozolomide and a protein kinase inhibitor
20070112177 - Adenosine receptor
20070105141 - Use of azetidinone compounds
20070105864 - Methods for inhibiting protein kinases
20070098727 - Use of cytokine expression to predict skin inflammation; methods of treatment
20070099273 - Refolded recombinant beta-secretase crystals and methods for preparing and using the same
20070099872 - Functionally selective alpha2c adrenoreceptor agonists
20070099875 - Aspartyl protease inhibitors
20070099898 - Heterocyclic aspartyl protease inhibitors
April 2007 - Schering-plough Corporation Patent Department (k-6-1, 1990) patents
20070093430 - Novel ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus
20070093477 - Alpha2c adrenoreceptor agonists
20070082900 - Methods for inhibiting protein kinases
20070082901 - Pyrazolopyrimidines as protein kinase inhibitors
20070082902 - Pyrazolopyrimidines as protein kinase inhibitors
20070082913 - Substituted heterocyclic compounds with cxcr3 antagonist activity
20070083044 - Pyrazolopyrimidines as protein kinase inhibitors
March 2007 - Schering-plough Corporation Patent Department (k-6-1, 1990) patents
20070048781 - Mammalian cytokines; related reagents and methods
20070049536 - Novel compounds as inhibitors of hepatitis c virus ns3 serine protease
February 2007 - Schering-plough Corporation Patent Department (k-6-1, 1990) patents
20070042968 - Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease
20070043045 - Novel high affinity thiophene-based and furan-based kinase ligands
20070036750 - Mcp1 fusions
20070037824 - Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
20070037831 - Methods of using pde 5 inhibitors for the treatment of congestive heart failure
20070028485 - Gel insoles with lower heel and toe recesses having thin spring walls
20070031349 - Rapidly absorbing oral formulations of pde 5 inhibitors
20070031401 - Catalytic domain of adam33 and methods of use thereof
20070032433 - Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
20070032434 - Novel compounds as inhibitors of hepatitis c virus ns3 serine protease
20070032495 - Pyrazolotriazines as kinase inhibitors
20070032502 - Quinazoline derivatives useful in cancer treatment
20070022630 - Arch support insole
20070025994 - Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
January 2007 - Schering-plough Corporation Patent Department (k-6-1, 1990) patents
20070020262 - Uses of mammalian cytokine: related reagents
20070021351 - Liver/plasma concentration ratio for dosing hepatitis c virus protease inhibitor
20070021387 - Florfenicol prodrug having improved water solubility
20070021494 - 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
20070021592 - Npc1l1 (npc3) and methods of use thereof
20070021611 - Pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
20070015731 - 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as cxc-chemokine receptor ligands
20070015774 - Quinazoline derivatives useful in cancer treatment
20070015807 - Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists
20070009558 - Sugar-free storage-stable antihistaminic syrups
20070010431 - Pharmaceutical formulations and methods of treatment using the same
20070010513 - Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists
20070010667 - Preparation and use of compounds as aspartyl protease inhibitors
20070004635 - Method of treating interferon non-responders using hcv protease inhibitor
20070004682 - Di-substituted oxadiazoles as cxc-chemokine receptor ligands
20070004745 - Methods of treating benign prostatic hyperplasia or lower urinary tract symptoms by using pde 5 inhibitors
December 2006 - Schering-plough Corporation Patent Department (k-6-1, 1990) patents
20060286103 - Stable antibody formulation
20060287248 - Asymmetric dosing methods
20060287254 - Use of substituted azetidinone compounds for the treatment of sitosterolemia
20060287294 - Aspartyl protease inhibitors
20060281688 - Administration of hcv protease inhibitors in combination with food to improve bioavailability
20060281689 - Method for modulating activity of hcv protease through use of a novel hcv protease inhibitor to reduce duration of treatment period
20060281695 - Control of parasites in animals by n-[(phenyloxy)phenyl]-1,1,1-trifluoromethanesulfonamide and n-[(phenylsulfanyl)phenyl]-1,1,1-trifluoromethanesulfonamide derivatives
20060281729 - Macrocyclic heterocyclic aspartyl protease inhibitors
20060281730 - Aspartyl protease inhibitors
20060281756 - Synthesis of 3-amino-4-substituted pyrazole derivatives
20060281778 - Compounds for inhibiting ksp kinesin activity
20060275297 - Mammalian cx3c chemokine antibodies
20060275366 - Controlled-release formulation
20060276404 - Medicaments and methods combining a hcv protease inhibitor and an akr competitor
20060276405 - Methods for treating hepatitis c
20060276406 - Methods of treating hepatitis c virus
20060276407 - Methods of treating hepatitis c virus
20060276448 - Heteroaryl substituted pyrazinyl-piperazine-piperidines with cxcr3 antagonist activity
20060276457 - Piperazine-piperidines with cxcr3 antagonist activity
20060276479 - Heterocyclic substituted piperazines with cxcr3 antagonist activity
20060276480 - Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
20060276495 - Treatment methods of nasal congestion and nasal obstruction
20060276506 - Compounds for the treatment of inflammatory disorders
November 2006 - Schering-plough Corporation Patent Department (k-6-1, 1990) patents
20060269516 - Interferon-igg fusion
20060269936 - Screening assay for tlr7, tlr8 and tlr9 agonists and antagonists
20060269993 - Dnaxccr10
20060270041 - Cell lines for production of replication-defective adenovirus
20060270697 - Treatment method
20060263364 - Mammalian chemokines; related reagents
20060264489 - Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
20060257365 - Combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection
20060258665 - Bridged ring nk1 antagonists
20060258699 - Compounds for inhibiting ksp kinesin activity
20060258863 - Synthesis of ccr5 antagonists
20060259989 - Sporadic tumor mouse model for drug discovery
20060252698 - Compounds for inhibiting cathepsin activity
20060252778 - Compounds for the treatment of inflammatory disorders
20060247320 - Compounds for inhibiting ksp kinesin activity
20060247437 - Preparation of ketone amides
20060247450 - Exo- and diastereo- selective syntheses of himbacine analogs
October 2006 - Schering-plough Corporation Patent Department (k-6-1, 1990) patents
20060241121 - Substituted piperazines as cb1 antagonists
20060241295 - Preparation of pharmaceutical salts of piperazine compounds
20060233810 - Methods and compositions for treating or preventing cancer
20060233825 - C. perfringens alpha toxoid vaccine
20060235025 - Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
20060229249 - Peptide substrates of a proteolytic adam33 polypeptide and assays using the same
20060229456 - Synthesis of temozolomide and analogs
20060223804 - Nk1 antagonists
20060223808 - Spirocyclic thrombin receptor antagonists
20060223821 - Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors
20060223856 - Piperidinyl piperidine derivatives useful as inhibitors of chemokine receptors
20060223864 - Thiadiazoles as cxc- and cc- chemokine receptor ligands
August 2006 - Schering-plough Corporation Patent Department (k-6-1, 1990) patents
20060172397 - Preparation of chiral propargylic alcohol and ester intermediates of himbacine analogs
20060173016 - Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
20060173017 - Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
20060173189 - Synthesis of himbacine analogs
July 2006 - Schering-plough Corporation Patent Department (k-6-1, 1990) patents
20060166960 - Imidazole and benzimidazole derivatives useful as histamine h3 antagonists
20060167029 - Mglur1 antagonists as therapeutic agents
20060159696 - Neutralizing epitope-based growth enhancing vaccine
20060159761 - Stable extended release oral dosage composition
20060160823 - Particulate-stabilized injectable pharmaceutical compositions of posaconazole
20060161994 - Functional assays for cholesterol absorption inhibitors
20060153802 - Mammalian chemokine reagents
20060154858 - Canine rankl and methods for preparing and using the same
20060154937 - Novel farnesyl protein transferase inhibitors and their use to treat cancer
20060154948 - Treating allergic and inflammatory conditions
20060147456 - Induction of apoptosis in toll-like receptor expressing tumor cells
20060148816 - 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
20060149060 - Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Schering-plough Corporation Patent Department (k-6-1, 1990) in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Schering-plough Corporation Patent Department (k-6-1, 1990) with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support
|
REGISTER now for FREE 
